Can You Take Tizanidine With Hydrocodone Safely?

Combining tizanidine with hydrocodone is something doctors prescribe regularly, but it does carry genuine risks, primarily excessive sedation and slowed breathing. The good news, based on large population studies, is that tizanidine appears to be one of the safer muscle relaxants to pair with an opioid. That said, “safer” is not the same as “safe,” and several personal factors can tip the balance in the wrong direction.

Why This Combination Gets Prescribed So Often

If you are dealing with back pain, neck pain, or a musculoskeletal injury, you may have been prescribed both a muscle relaxant and a pain reliever at the same time. That is not unusual. A large analysis of U.S. prescribing patterns from 2005 to 2016 found that hydrocodone-acetaminophen was the single most common drug prescribed alongside a new muscle relaxant prescription.¹ Tizanidine and hydrocodone treat different aspects of the same problem: tizanidine works centrally to reduce muscle spasm, while hydrocodone dulls the pain signal itself. Together, they can provide relief that neither manages alone.

The concern is that both drugs depress the central nervous system. Hydrocodone, as an opioid, slows breathing and reduces alertness. Tizanidine, as a centrally acting alpha-2 adrenergic agonist, lowers blood pressure, causes drowsiness, and can amplify the sedating effects of other CNS depressants. Stack them together and the sedation, dizziness, and respiratory depression from each drug can compound. That theoretical worry is the reason researchers have tried to measure how much real-world harm actually results from these combinations.

What the Overdose Data Actually Shows

Two large studies have looked specifically at opioid overdose risk when muscle relaxants are used at the same time. Their findings on tizanidine are reassuring, though with caveats.

A study published in Neurology compared the risk of opioid overdose across seven different muscle relaxants, all used alongside prescription opioids, using cyclobenzaprine (Flexeril) as the reference point since it is the most commonly prescribed muscle relaxant in the U.S. In the 30-day analysis, tizanidine showed essentially the same overdose risk as cyclobenzaprine. Baclofen, by contrast, was associated with roughly two and a half times the overdose risk compared to cyclobenzaprine, and carisoprodol also trended higher.² These findings held up across multiple analysis methods, including among patients without a history of substance abuse.

A separate population-based cohort study looked at the question from a broader angle, comparing people who used opioids and muscle relaxants together against people who used opioids alone. The combined estimate suggested a modest overall increase in overdose risk for the combination. But when the researchers broke the data down by specific muscle relaxant, the drugs driving that signal were baclofen and carisoprodol, not tizanidine. Risk also climbed with longer treatment duration: people who used the combination for more than 60 days had a meaningfully higher overdose rate than those who used it for two weeks or less.³

So the pattern from the overdose literature is fairly consistent: among muscle relaxants paired with opioids, tizanidine does not appear to be a standout offender. Baclofen and carisoprodol are the ones that consistently show elevated overdose rates.

The Specific Opioid Matters More Than You Might Think

One of the more surprising findings in recent research is that the risk of injury from combining a muscle relaxant with an opioid depends heavily on which opioid is involved. A large study published in Clinical Pharmacology & Therapeutics examined hundreds of thousands of patients using muscle relaxants concurrently with hydrocodone, oxycodone, or tramadol. The results for tizanidine varied dramatically depending on the opioid partner.

When tizanidine was combined with oxycodone, the injury risk was elevated. But when tizanidine was combined with tramadol, it was actually associated with a lower injury rate than cyclobenzaprine. For hydrocodone specifically, the injury rates for tizanidine did not reach statistical significance, meaning the data could not distinguish whether tizanidine made things better or worse compared to the reference muscle relaxant.⁴ That is actually the most common real-world pairing, since this same study identified nearly 350,000 concurrent users of muscle relaxants with hydrocodone.

The order in which the two drugs are started also seems to matter. In the oxycodone group, the elevated injury risk for tizanidine appeared when the muscle relaxant was the drug that triggered the overlap, meaning it was added to an existing opioid prescription. The researchers concluded that the relative safety of different muscle relaxants is not one-size-fits-all; it depends on the specific opioid involved and the sequence of prescribing.

Risk Factors That Shift the Equation

Even though tizanidine’s track record with hydrocodone looks relatively favorable in the population data, individual circumstances can make the combination riskier. Several factors emerged consistently across the research.

Treatment duration: Short courses carry less risk. The cohort study mentioned earlier found that overdose rates were no different from opioid-only use during the first two weeks, but climbed meaningfully when the combination continued beyond 60 days.³
Opioid dose: People on higher daily opioid doses had a notably higher overdose risk when a muscle relaxant was added. The threshold identified in the data was a daily opioid dose equivalent to 50 mg or more of morphine.
Benzodiazepine co-use: If you are also taking a benzodiazepine for anxiety or sleep, adding both tizanidine and hydrocodone means three CNS depressants at once. That triple combination showed elevated overdose risk in the same study.
Liver disease: Tizanidine is extensively metabolized by the liver. In people with liver impairment, the drug clears more slowly, which can amplify its sedating and blood-pressure-lowering effects. Clinical guidance specifically recommends avoiding tizanidine in patients with liver disease.⁵
Older age: Older adults are more sensitive to the sedating and blood-pressure-dropping effects of both drugs. Reduced doses are recommended for this group when tizanidine is used at all.

Alcohol is the wild card not captured well in these studies. Both tizanidine and hydrocodone interact with alcohol in ways that intensify sedation and respiratory depression. Even moderate drinking while on this combination substantially raises the danger, and this is one area where the risk is unambiguous rather than statistical.

How Tizanidine Compares to Other Muscle Relaxants

If you are wondering whether tizanidine is the right muscle relaxant to pair with your opioid, it helps to know how it stacks up against the alternatives. A review published in the Journal of Pain Research compared tizanidine’s safety profile across several dimensions and found that it had lower rates of injury, delirium, falls, and opioid overdose compared to baclofen. Unlike carisoprodol and diazepam, tizanidine does not carry significant abuse potential or physical dependence risk. And unlike metaxalone, it does not pose a risk of serotonin syndrome when combined with serotonergic drugs like certain antidepressants.⁶

The overdose data reinforces this picture. Across the studies discussed earlier, baclofen and carisoprodol were consistently the muscle relaxants most strongly linked to overdose and injury when paired with opioids. Tizanidine, cyclobenzaprine, methocarbamol, and metaxalone generally clustered together with lower or statistically indistinguishable risk. For the specific pairing with hydrocodone, tizanidine did not stand out as particularly dangerous compared to other options in the class.⁴

That said, tizanidine has its own quirks. It can drop blood pressure sharply, especially with the first dose or when the dose is increased. It causes drowsiness more consistently than some alternatives. And its heavy reliance on liver metabolism means it interacts with a long list of other drugs, particularly certain antibiotics like ciprofloxacin and the antidepressant fluvoxamine, which can dramatically increase tizanidine levels in the blood. Your prescriber should be checking for these interactions, but it is worth knowing about them yourself.

What to Watch For If You Are Taking Both

If your doctor has prescribed both tizanidine and hydrocodone, the combination is not inherently reckless. Hundreds of thousands of people have used these drugs together. But you should know the warning signs that the sedation is stacking up dangerously.

Excessive drowsiness is the first signal. Both drugs cause it independently, and together the effect can be stronger than you expect, particularly during the first few days. Feeling unusually foggy, having trouble staying awake during the day, or noticing that your balance is off are signs that the combined sedation is significant. Shallow or slowed breathing, especially during sleep, is the most dangerous consequence of combining CNS depressants. If someone near you notices you making unusual breathing sounds while sleeping, or you wake up gasping, that warrants medical attention.

Dizziness when standing up is worth paying attention to, particularly with tizanidine. The drug can lower blood pressure enough to make you lightheaded when you get up from a chair or bed. Adding hydrocodone, which can also lower blood pressure, makes falls a real concern, especially for older adults. Getting up slowly and holding onto something until you are steady is a simple precaution that matters.

Timing also plays a role in managing the risks. Taking both drugs at exactly the same time produces a higher peak of combined CNS depression than staggering the doses. Some clinicians will have you take tizanidine at bedtime to use its sedating properties for sleep while scheduling hydrocodone separately during the day. This is a conversation to have with your prescriber rather than adjusting timing on your own.

The CYP1A2 Problem

One pharmacological wrinkle with tizanidine that does not get enough attention is how it is processed in the body. Tizanidine relies heavily on a single liver enzyme called CYP1A2 for metabolism. Drugs that block this enzyme can cause tizanidine levels to spike dramatically. Ciprofloxacin, a widely prescribed antibiotic, is the most notorious offender and is considered a contraindicated combination with tizanidine. Fluvoxamine, an antidepressant, is another.

Why does this matter for the hydrocodone question? Because if you are already on tizanidine and hydrocodone and you develop an infection that gets treated with ciprofloxacin, your tizanidine blood levels could surge without any change in your tizanidine dose. That surge could intensify sedation and blood pressure drops while hydrocodone is already on board, creating a more dangerous combination than what you had been tolerating. This is the kind of three-way interaction that a pharmacist is better positioned to catch than a busy physician, so filling all your prescriptions at one pharmacy is a practical safeguard.

Smoking is another variable. Cigarette smoke induces CYP1A2 activity, which means smokers actually clear tizanidine faster. If you quit smoking while taking tizanidine, your blood levels of the drug may rise, and the combination with hydrocodone could become more sedating. This is an underappreciated interaction that can blindside people who are trying to quit.

When to Use This Combination and When to Rethink It

The research supports a few practical principles. For short-term use after an acute injury or flare-up, particularly at low to moderate opioid doses and without other CNS depressants on board, combining tizanidine with hydrocodone is a defensible clinical choice. The population data does not show excess overdose or injury risk for tizanidine-hydrocodone pairings in the short term, and tizanidine’s lower abuse potential compared to some alternatives is a genuine advantage.⁶

The calculus shifts when the combination extends beyond a few weeks. The data showing rising overdose risk with longer treatment duration is not specific to tizanidine, but it applies to all opioid-muscle-relaxant combinations and should prompt a conversation about whether both drugs are still needed.³ Chronic musculoskeletal pain is better managed with exercise, physical therapy, and non-opioid approaches when possible, and continuing both drugs indefinitely out of habit rather than ongoing necessity is where the risk-benefit ratio starts to erode.

For older adults, people with liver disease, or anyone already on benzodiazepines, the combination requires extra caution. If tizanidine is used at all in these groups, doses should start low.⁵ For people with liver impairment, a different muscle relaxant that does not depend so heavily on hepatic metabolism may be preferable. And for anyone on a daily opioid dose equivalent to 50 mg or more of morphine, adding any muscle relaxant raises the stakes enough to warrant a careful discussion about whether the muscle relaxant is truly contributing to pain relief or just adding sedation.

The Drugs That Are Actually More Dangerous to Combine

Part of what makes the tizanidine-hydrocodone question tricky is that the real danger signals in opioid-muscle-relaxant research point elsewhere. Baclofen consistently shows the highest overdose risk when combined with opioids, with roughly two and a half times the rate seen with cyclobenzaprine in the Neurology study.² Carisoprodol (Soma) appears nearly as concerning, and it adds the complication of its own abuse potential since it is metabolized into meprobamate, a controlled substance. In the injury-risk study, carisoprodol with oxycodone showed the highest hazard ratio of any combination examined.⁴

Benzodiazepines combined with opioids are in a different league of risk altogether. The FDA has issued a boxed warning on the combination, and the overdose data supports it. Adding a benzodiazepine to an opioid-muscle-relaxant regimen consistently amplifies the danger in ways that dwarf the muscle-relaxant-alone signal. If you are currently on all three classes of drug, that is the conversation most worth having with your doctor, because reducing or eliminating the benzodiazepine may do more for your safety than any switch between muscle relaxants would.

1
JAMA Network Open. Assessment of Physician Prescribing of Muscle Relaxants in the United States, 2005-2016
2
PubMed. Comparative Risk of Opioid Overdose With Concomitant Use of Prescription Opioids and Skeletal Muscle Relaxants
3
PubMed. Risk of Opioid Overdose Associated With Concomitant Use of Opioids and Skeletal Muscle Relaxants: A Population-Based Cohort Study
4
PubMed Central. Comparative Risk of Injury with Concurrent Use of Opioids and Skeletal Muscle Relaxants
5
Springer Link / Drugs & Aging. Pharmacotherapy for Spine-Related Pain in Older Adults
6
Dove Press / Journal of Pain Research. Tizanidine: Advances in Pharmacology & Therapeutics and Drug Formulations